American Healthcare REIT, Inc.
At today's price, American Healthcare REIT, Inc. (AHR) is priced for today's economics sustained for ~7.8 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
Normalized funds from operations grew fast: first-quarter 2026 came in at $0.50 per diluted share, up 31.6 percent from $0.38, and management raised full-year guidance to $2.09 to $2.30, targeting roughly 20 percent growth. At $46.55 the trust trades near 37 times adjusted funds from operations, the very top of the REIT group. The price embeds top-of-range growth sustained for about six years, the most demanding end of the scale. The engine is the operating senior-housing portfolio, where the
Is AHR overvalued? See what's priced in →
504 institutional managers reported holding AHR in 13F filings for the quarter ended 2026-03-31. 57 opened new positions that quarter. Held by BlackRock, Vanguard Group, State Street, among others. On the short side, 16.6M shares were sold short as of the 2026-06-15 count, about 9% of shares outstanding (7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
AHR's share count grew 4.3% over the past five years even with $19.69M spent on repurchases. It pays a dividend, and has paid one every year in our records (10 and counting); the current rate is $1.00 a share annually. Cash returned over the past three years: $364.44M in dividends and $318k in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at AHR over the trailing three years: 2024: 3 buys totaling $2.35M. 13 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
AHR's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2024-03-23 | -0.8% | +0.4% |
| 2024-05-15 | -0.4% | +12.2% |
| 2024-08-10 | +3.3% | +47.0% |
| 2024-11-14 | +1.3% | +9.3% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
AHR's latest 8-K filings: 2026-06-25 (items 5.07); 2026-06-18 (items 7.01, 8.01, 9.01); 2026-05-28 (items 8.01, 9.01); 2026-05-22 (items 8.01, 9.01); 2026-05-07 (items 2.02, 7.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.